Compare HBM & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBM | RVTY |
|---|---|---|
| Founded | 1927 | 1937 |
| Country | Canada | United States |
| Employees | 3072 | N/A |
| Industry | Metal Mining | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.7B |
| IPO Year | 2005 | 1994 |
| Metric | HBM | RVTY |
|---|---|---|
| Price | $25.08 | $101.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $25.00 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 4.5M | 1.2M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | 0.07% | ★ 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $30.66 | $6.37 |
| Revenue Next Year | $14.54 | $5.10 |
| P/E Ratio | ★ $21.47 | $47.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.04 | $81.22 |
| 52 Week High | $28.74 | $118.30 |
| Indicator | HBM | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 67.59 |
| Support Level | $23.27 | $82.88 |
| Resistance Level | $26.40 | $103.04 |
| Average True Range (ATR) | 1.07 | 4.33 |
| MACD | 0.00 | 1.56 |
| Stochastic Oscillator | 86.23 | 97.72 |
Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.